PlexusDx vs Rex MD: Compounded GLP-1s vs Wegovy Pill Compared

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Rex MD offers FDA-approved branded Wegovy in two forms: an oral pill at $349/month and an injectable pen at $499/month. PlexusDx offers compounded semaglutide injection starting at $189/month month-to-month, dropping to $149/month on a six-month plan. The core trade-off is regulatory status and route versus price. Wegovy is FDA-approved and available in both oral and injectable forms; compounded semaglutide is not FDA-approved, is injectable only in PlexusDx's lineup, and costs $160–$350 less per month than Rex MD's options. If you prioritize FDA approval or prefer an oral medication, Rex MD's Wegovy pill is the only option in this comparison. If you are comfortable with compounded medication and injectable administration, PlexusDx delivers the same active ingredient at a significantly lower recurring cost.

At-a-glance comparison

Sources: Rex MD weight-management page and semaglutide product page (captured 2026-09-04); PlexusDx alternatives page (captured 2026-09-06). Rex MD pricing extracted from public pages; checkout was not completed, so confirm final all-in cost at purchase. For the Wegovy pen, confirm whether any separate program fee applies to the $499 medication price.

Like-for-like pricing: Injectable semaglutide

Both Rex MD's Wegovy pen and PlexusDx's compounded semaglutide injection deliver semaglutide subcutaneously. The difference is regulatory approval and price.

• Rex MD Wegovy pen: $499/month, $5,988 over twelve months (our calculation). FDA-approved branded medication.
• PlexusDx semaglutide injection (month-to-month): $189/month, $2,268 over twelve months (our calculation). Compounded medication from licensed 503A pharmacies.
• Difference: PlexusDx is $310/month or $3,720/year lower (our calculation).

If you commit to a three-month or six-month plan with PlexusDx, the gap widens:

• PlexusDx three-month plan: $169/month prepaid rate, $2,028 over twelve months (our calculation, assuming continuous three-month renewals).
• PlexusDx six-month plan: $149/month prepaid rate, $1,788 over twelve months (our calculation, assuming two six-month commitments).

At the six-month rate, PlexusDx is $350/month or $4,200/year below Rex MD's Wegovy pen price (our calculation). Both providers state that price remains constant across titration doses, so these figures hold whether you are at 0.25 mg or 2.4 mg weekly.

Oral vs injectable: Rex MD Wegovy pill and PlexusDx

Rex MD's Wegovy pill is $349/month, or $4,188 over twelve months (our calculation). It is the only oral semaglutide option in this comparison and the only FDA-approved oral GLP-1 widely available through telehealth. PlexusDx's compounded semaglutide injection at $189/month is $160/month ($1,920/year, our calculation) less expensive but requires subcutaneous injection. The route difference is significant: oral administration means no needles and no refrigeration; injection typically means once-weekly dosing and direct systemic delivery.

If needle aversion or travel convenience makes oral dosing non-negotiable, Rex MD's pill is the clear path. If you are comfortable with self-injection and cost is the priority, PlexusDx's injection offers the lower price and the same active ingredient in compounded form.

Regulatory status: FDA-approved vs compounded

Rex MD's Wegovy—both pill and pen—is FDA-approved. The agency reviewed clinical trial data for safety, efficacy, and manufacturing quality before granting approval. That review does not exist for compounded medications. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

PlexusDx works with licensed 503A compounding pharmacies. These pharmacies operate under state board oversight and prepare medications individually for patients with a valid prescription. The active ingredient—semaglutide—is the same molecule in both contexts, but the formulation, excipients, and regulatory pathway differ.

For some patients, FDA approval is a non-negotiable requirement. For others, the clinical profile of the active ingredient and the licensing of the prescriber and pharmacy are sufficient assurance, and cost becomes the deciding factor.

What about tirzepatide?

Rex MD's documented offerings are semaglutide-only (Wegovy pill and pen). PlexusDx offers compounded tirzepatide injection at $289/month month-to-month, $269/month prepaid on a three-month plan, and $249/month prepaid on a six-month plan. Tirzepatide is a dual GIP/GLP-1 agonist and has demonstrated greater average weight loss than semaglutide in head-to-head trials. If you want tirzepatide and Rex MD does not offer it, PlexusDx becomes the option in this two-provider comparison.

Evidence limitations and checkout advice

Rex MD pricing was captured from public product pages on September 4, 2026. The researcher's cloud browser timed out before account creation or checkout, so these figures were not verified at the payment screen. The Wegovy pen page states "$499/month medication cash price via NovoCare pathway, prescription through Rex MD," and a note in our research advises confirming whether any separate program fee applies. We report what was published; you should confirm the final all-in price—including any consultation, membership, or service fees—at checkout before committing.

No promotional or first-month discount was documented for Rex MD. The figures in this article are presented as standard ongoing rates.

Choose Rex MD Wegovy pill if…

• You require FDA-approved medication and will not consider compounded alternatives.
• You strongly prefer oral administration—no injections, no needles, no refrigeration.
• You value the regulatory review and post-market surveillance that accompany branded drugs.
• The $349/month price fits your budget and the $160/month premium over compounded injection is acceptable for the oral route and approval status.

Choose Rex MD Wegovy pen if…

• You require FDA-approved medication in injectable form.
• You want the branded Wegovy pen device and the support infrastructure Novo Nordisk provides.
• You have confirmed at checkout that $499/month is the complete recurring cost with no additional fees.
• The $310/month premium over PlexusDx's compounded injection is justified by the approval status for your situation.

Choose PlexusDx compounded semaglutide injection if…

• You are comfortable with compounded medication and understand it is not FDA-approved.
• Cost is a priority: you want to spend $189/month instead of $499/month for injectable semaglutide, or $189/month instead of $349/month by accepting injection over oral.
• You prefer month-to-month flexibility or want to lock in a lower rate with a three-month ($169/month prepaid) or six-month ($149/month prepaid) commitment.
• You want the option to add tirzepatide ($289/month month-to-month, $249/month prepaid on six-month plan) without switching providers.

Methodology and freshness

Rex MD pricing and program details were captured from the provider's public weight-management page (rexmd.com/weight-management) and semaglutide product page (rexmd.com/our-medications/weight-management/semaglutide) on September 4, 2026. The researcher's cloud browser timed out before account creation, so checkout was not completed and the figures represent what was published on indexed public pages. PlexusDx pricing was captured from the alternatives reference page on September 6, 2026. Twelve-month cost projections and per-month differences are our calculations, derived by multiplying stated monthly rates by twelve or applying the prepaid per-month rate across twelve months of renewals. We label all such derived figures as "our calculation." Where evidence conflicts or checkout was not reached, we state the limitation plainly and advise confirming at purchase. Review data were checked but no ratings, volumes, or thematic excerpts were captured in the research pass, so no review comparison appears in this article. This article was produced under PlexusDx's conflict-of-interest disclosure: we use the same evidence standards for our own program and competing programs, and competitors may win comparisons where evidence supports it.

Frequently Asked Questions

Is compounded semaglutide the same active ingredient as branded Wegovy?

Compounded semaglutide uses the same active ingredient as Wegovy—semaglutide—but it is not FDA-approved and is prepared by a compounding pharmacy rather than a commercial manufacturer. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. A licensed clinician determines whether a prescription is appropriate for each patient.

Why is Rex MD's Wegovy pen $499 per month when PlexusDx charges $189?

Rex MD offers FDA-approved branded Wegovy manufactured by Novo Nordisk; PlexusDx offers compounded semaglutide from licensed 503A pharmacies. The branded product carries FDA approval, post-market surveillance, and the manufacturer's support infrastructure. The compounded version does not have FDA approval but costs significantly less. The $310 monthly difference reflects the regulatory and manufacturing distinction.

Does PlexusDx offer an oral semaglutide option?

PlexusDx's semaglutide injection is the product featured in this comparison. The provider does offer other formulations; check the weight-management protocols collection or contact support to confirm current oral options and pricing. Rex MD's Wegovy pill at $349/month is the only oral semaglutide documented in this two-provider comparison.

Will my dose increase change my monthly price with either provider?

Both providers state that price is locked across titration doses. Rex MD's pages say "lowest cost locked across titration doses" for the pill and "regardless of dosage strength for eligible self-pay patients" for the pen. PlexusDx's pricing is the same at every dose. Confirm this policy at checkout, but the public documentation supports constant pricing whether you are at 0.25 mg or 2.4 mg weekly.

Can I switch from Rex MD Wegovy to PlexusDx compounded semaglutide or vice versa?

Switching providers is possible, but coordination is your responsibility. You will need a new clinical intake and prescription from the new provider. Timing the transition to avoid a gap or overlap in medication supply requires planning. Neither provider guarantees continuity of your current dose when you transfer, and your new clinician will determine the appropriate starting or continuation dose independently.

Sources

• PlexusDx alternatives reference page, accessed September 6, 2026.
• Rex MD weight-management page (rexmd.com/weight-management), accessed September 4, 2026.
• Rex MD semaglutide product page (rexmd.com/our-medications/weight-management/semaglutide), accessed September 4, 2026.
• PlexusDx Trustpilot profile, rating and review distribution captured September 4, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.